Literature DB >> 7871959

Myelofibrosis in severe combined immunodeficiency due to vitamin D deficiency rickets.

Y A al-Eissa1, S A al-Mashhadani.   

Abstract

An infant with severe combined immunodeficiency is described in whom a refractory anemia and thrombocytopenia developed after the age of 6 months, associated with poor growth and frequent episodes of upper respiratory tract infections and diarrhea. He required frequent blood and platelet transfusions. Bone marrow biopsy provided evidence that the anemia and thrombocytopenia were the results of myelofibrosis which was secondary to vitamin D deficiency. Therapy with 1,25-dihydroxycholecalciferol resulted in resolution of the hematologic and skeletal abnormalities, but he remained susceptible to recurrent serious infections and died at the age of 13 months.

Entities:  

Mesh:

Year:  1994        PMID: 7871959     DOI: 10.1159/000204211

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Vitamin D-dependent rickets: a resurgence of the rachitic lung in the 21st century.

Authors:  Ana S C Fernandes; Sandra Lobo; Ana Rita Sandes; Carla Simão; Luisa Lobo; Teresa Bandeira
Journal:  BMJ Case Rep       Date:  2015-10-19

2.  Nutritional rickets presenting with myelofibrosis.

Authors:  Bhanu Kiran Bhakhri; Pradeep K Debata
Journal:  Indian J Pediatr       Date:  2010-09-30       Impact factor: 1.967

3.  Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.

Authors:  Inga Hofmann; Mitchell J Geer; Timo Vögtle; Andrew Crispin; Dean R Campagna; Alastair Barr; Monica L Calicchio; Silke Heising; Johanna P van Geffen; Marijke J E Kuijpers; Johan W M Heemskerk; Johannes A Eble; Klaus Schmitz-Abe; Esther A Obeng; Michael Douglas; Kathleen Freson; Corinne Pondarré; Rémi Favier; Gavin E Jarvis; Kyriacos Markianos; Ernest Turro; Willem H Ouwehand; Alexandra Mazharian; Mark D Fleming; Yotis A Senis
Journal:  Blood       Date:  2018-06-13       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.